The Leukemia and Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer (Leukemia & Lymphoma Society, n.d.). Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada (Leukemia & Lymphoma Society, n.d.). LLS's mission is to cure leukemia, lymphoma, multiple myeloma and improve the quality of life of patients and their families. LLS funds life-saving blood cancer research around the world, provides free information and support services, and is the voice of all blood cancer patients seeking access to quality, affordable, coordinated care (Leukemia & Lymphoma Society , n.d.). Every 4 minutes someone is diagnosed with blood cancer; and every 10 minutes someone dies from blood cancer (Leukemia & Lymphoma Society, n.d.). In 2013, more than 3,000 Missourians were diagnosed with blood cancer. LLS has currently invested nearly $4 million in Missouri to find cancer cures (Leukemia & Lymphoma Society, n.d.). Meg Boyko is the patient access, education and advocacy manager at the St. Louis Gateway Chapter Leukemia & Lymphoma Society and a mentor to the Field Experience Project for this article. She spends countless hours educating patients, families, communities and political leaders about blood cancers while promoting parity for oral and intravenous chemotherapy treatments. She is a strong advocate who has a way of drawing people in and encouraging them to participate in LLS's mission to cure blood cancers and help improve the quality of life for patients and their families. It brings out each supporter's strengths and uses them to benefit the needs of those suffering from blood cancer. The supporters work well together and feel... at the center of the paper... anti-cancer drugs. It is estimated that approximately 10% of cancer patients do not fill oral prescriptions and, therefore, do not receive recommended cancer treatment due to high out-of-pocket costs. A 2009 study found that patients with an out-of-pocket cost of more than $200 per prescription were at least three times less likely to fill their prescription for oral cancer drugs, compared to patients with out-of-pocket costs of $100 or less. Going off your medications can lead to expensive checkups or hospital stays, among other things. Equitable access to oral medications can help prevent this outcome. Lower out-of-pocket costs for patients mean they are more likely to adhere to their cancer regimen as several studies have shown that the higher the cost-sharing amounts, the less likely patients are to stay on treatment.